Cadila Healthcare has received final approval from USFDA to market Clobetasol Propionate Cream, (US RLD Temovate Cream), 0.05%. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.
Clobetasol Propionate is a topical (for the skin) steroid used to treat inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
